Physician profile
Megan Mann
NPI 1073845269
$700.33
in general payments reported to CMS, 2019-2025
13 companies · $145 in 2025
The $145 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $67.87 · 2022: $19.76 · 2023: $206 · 2024: $262 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $613.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $612.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $152.09 | 2021-2024 | |
| Mayne Pharma Commercial LLC | $118.75 | 2022-2025 | |
| Exeltis, USA INC. | $87.81 | 2023-2025 | Slynd |
| Evofem Biosciences, INC. | $63.18 | 2023-2025 | Phexxi, Solosec, Phexx |
| Sumitomo Pharma America, INC. | $50.13 | 2023 | Myfembree |
| Optumhealth Care Solutions, LLC | $47.28 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Medtronic, INC. | $44.14 | 2024 | Interstim |
| Exact Sciences Corporation | $37.98 | 2023-2024 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $30.10 | 2023-2024 | |
| Astellas Pharma US INC | $19.74 | 2023 | Myrbetriq |
| Millicent US INC | $19.23 | 2025 | Intrarosa, Femlyv |
| Baxter Healthcare | $15.31 | 2024 | Perclot |
| Pfizer INC. | $14.59 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Mann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.